The proposed study, "Placebo-controlled study of EEG biofeedback therapy as an adjunct
treatment for PTSD, evaluating symptoms and EEG dynamics", will investigate the brain
dynamics associated with PTSD symptom reduction associated with EEG biofeedback therapy or
sham EEG biofeedback in addition to treatment as usual at the Naval Medical Center, San Diego
(NMCSD) OASIS program.
EEG biofeedback treatment protocols for PTSD and other disorders have been developed and
honed by private practice clinicians over the past 25 years, during which EEG biofeedback has
become an increasingly popular adjunct therapy.
The reported success of EEG biofeedback as a non-drug intervention with lasting efficacy
warrants a clinical study investigating not only symptom reduction, but also the underlying
neurobiological mechanism. To this end, we propose a study using high density EEG recordings
before and after treatment for PTSD symptoms to determine which brain activities correlate
with reported symptom changes.
The proposed study could expand treatment alternatives for servicemen with PTSD. If EEG
biofeedback is shown to improve symptom reduction over the placebo controlled condition, it
would offer a non-pharmacological intervention that would avoid undesirable side effects, and
accelerate recovery compared with the current standard of care.